Comprehensive analysis of microRNAs in breast cancer
详细信息 查看全文
- 作者：Hong-Tai Chang (1) (2)
Sung-Chou Li (3)
Meng-Ru Ho (4)
Hung-Wei Pan (5)
Luo-Ping Ger (5)
Ling-Yueh Hu (6)
Shou-Yu Yu (5)
Wen-Hsiung Li (4) (7)
Kuo-Wang Tsai (5) (8) - 刊名：BMC Genomics
- 出版年：2012
- 出版时间：December 2012
- 年：2012
- 卷：13
- 期：7-supp
- 全文大小：539KB
- 参考文献：1. Gravgaard KH, Lyng MB, Laenkholm AV, Sokilde R, Nielsen BS, Litman T, Ditzel HJ: The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer. / Breast cancer research and treatment 2012.
2. Yekta S, Shih IH, Bartel DP: MicroRNA-directed cleavage of HOXB8 mRNA. / Science (New York, NY) 2004,304(5670):594鈥?96. CrossRef
3. Newman MA, Hammond SM: Emerging paradigms of regulated microRNA processing. / Genes & development 2010,24(11):1086鈥?092. CrossRef
4. Trabucchi M, Briata P, Filipowicz W, Rosenfeld MG, Ramos A, Gherzi R: How to control miRNA maturation? / RNA biology 2009,6(5):536鈥?40. CrossRef
5. Slezak-Prochazka I, Durmus S, Kroesen BJ, van den Berg A: MicroRNAs, macrocontrol: regulation of miRNA processing. / RNA (New York, NY) 2010,16(6):1087鈥?095. CrossRef
6. Fernandez-Valverde SL, Taft RJ, Mattick JS: Dynamic isomiR regulation in Drosophila development. / RNA (New York, NY) 2010,16(10):1881鈥?888. CrossRef
7. Guo L, Lu Z: Global expression analysis of miRNA gene cluster and family based on isomiRs from deep sequencing data. / Comput Biol Chem 2010,34(3):165鈥?71. CrossRef
8. Cloonan N, Wani S, Xu Q, Gu J, Lea K, Heater S, Barbacioru C, Steptoe AL, Martin HC, Nourbakhsh E, / et al.: MicroRNAs and their isomiRs function cooperatively to target common biological pathways. / Genome biology 2011,12(12):R126. CrossRef
9. Guo L, Yang Q, Lu J, Li H, Ge Q, Gu W, Bai Y, Lu Z: A comprehensive survey of miRNA repertoire and 3' addition events in the placentas of patients with pre-eclampsia from high-throughput sequencing. / PloS one 2011,6(6):e21072. CrossRef
10. Li SC, Liao YL, Chan WC, Ho MR, Tsai KW, Hu LY, Lai CH, Hsu CN, Lin WC: Interrogation of rabbit miRNAs and their isomiRs. / Genomics 2011,98(6):453鈥?59. CrossRef
11. Guo L, Li H, Liang T, Lu J, Yang Q, Ge Q, Lu Z: Consistent isomiR expression patterns and 3' addition events in miRNA gene clusters and families implicate functional and evolutionary relationships. / Molecular biology reports 2012,39(6):6699鈥?706. CrossRef
12. Humphreys DT, Hynes CJ, Patel HR, Wei GH, Cannon L, Fatkin D, Suter CM, Clancy JL, Preiss T: Complexity of murine cardiomyocyte miRNA biogenesis, sequence variant expression and function. / PloS one 2012,7(2):e30933. CrossRef
13. Li SC, Liao YL, Ho MR, Tsai KW, Lai CH, Lin WC: miRNA arm selection and isomiR distribution in gastric cancer. / BMC Genomics 2012,13(Suppl 1):S13. CrossRef
14. Chan SH, Wu CW, Li AF, Chi CW, Lin WC: miR-21 microRNA expression in human gastric carcinomas and its clinical association. / Anticancer Res 2008,28(2A):907鈥?11.
15. Chen Z, Zeng H, Guo Y, Liu P, Pan H, Deng A, Hu J: miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc. / J Exp Clin Cancer Res 2010, 29:151. CrossRef
16. Hausler SF, Keller A, Chandran PA, Ziegler K, Zipp K, Heuer S, Krockenberger M, Engel JB, Honig A, Scheffler M, / et al.: Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. / Br J Cancer 2010,103(5):693鈥?00. CrossRef
17. Theodore SC, Rhim JS, Turner T, Yates C: MiRNA 26a expression in a novel panel of African American prostate cancer cell lines. / Ethn Dis 2010,20(1 Suppl 1):S1. 96鈥?00
18. Yu S, Lu Z, Liu C, Meng Y, Ma Y, Zhao W, Liu J, Yu J, Chen J: miRNA-96 suppresses KRAS and functions as a tumor suppressor gene in pancreatic cancer. / Cancer research 2010,70(14):6015鈥?025. CrossRef
19. Volinia S, Galasso M, Sana ME, Wise TF, Palatini J, Huebner K, Croce CM: Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. / Proceedings of the National Academy of Sciences of the United States of America 2012,109(8):3024鈥?029. CrossRef
20. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY: MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. / RNA (New York, NY 2008,14(11):2348鈥?360. CrossRef
21. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, / et al.: MicroRNA gene expression deregulation in human breast cancer. / Cancer research 2005,65(16):7065鈥?070. CrossRef
22. Kong W, Yang H, He L, Zhao JJ, Coppola D, Dalton WS, Cheng JQ: MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. / Molecular and cellular biology 2008,28(22):6773鈥?784. CrossRef
23. Adams BD, Furneaux H, White BA: The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA and protein expression in breast cancer cell lines. / Mol Endocrinol 2007,21(5):1132鈥?147. CrossRef
24. Cui W, Zhang Y, Hu N, Shan C, Zhang S, Zhang W, Zhang X, Ye L: miRNA-520b and miR-520e sensitize breast cancer cells to complement attack via directly targeting 3'UTR of CD46. / Cancer Biol Ther 2010,10(3):232鈥?41. CrossRef
25. Kastl L, Brown I, Schofield AC: miRNA-34a is associated with docetaxel resistance in human breast cancer cells. / Breast cancer research and treatment 2012.
26. Tan Y, Zhang B, Wu T, Skogerbo G, Zhu X, Guo X, He S, Chen R: Transcriptional inhibiton of Hoxd4 expression by miRNA-10a in human breast cancer cells. / BMC Mol Biol 2009, 10:12. CrossRef
27. Ryu S, Joshi N, McDonnell K, Woo J, Choi H, Gao D, McCombie WR, Mittal V: Discovery of novel human breast cancer microRNAs from deep sequencing data by analysis of pri-microRNA secondary structures. / PloS one 2011,6(2):e16403. CrossRef
28. Bockmeyer CL, Christgen M, Muller M, Fischer S, Ahrens P, Langer F, Kreipe H, Lehmann U: MicroRNA profiles of healthy basal and luminal mammary epithelial cells are distinct and reflected in different breast cancer subtypes. / Breast cancer research and treatment 2011,130(3):735鈥?45. CrossRef
29. Buffa FM, Camps C, Winchester L, Snell CE, Gee HE, Sheldon H, Taylor M, Harris AL, Ragoussis J: microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. / Cancer research 2011,71(17):5635鈥?645. CrossRef
30. Hannafon BN, Sebastiani P, de las Morenas A, Lu J, Rosenberg CL: Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer. / Breast Cancer Res 2011,13(2):R24. CrossRef
31. Morin RD, O'Connor MD, Griffith M, Kuchenbauer F, Delaney A, Prabhu AL, Zhao Y, McDonald H, Zeng T, Hirst M, / et al.: Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. / Genome Res 2008,18(4):610鈥?21. CrossRef
32. Fehniger TA, Wylie T, Germino E, Leong JW, Magrini VJ, Koul S, Keppel CR, Schneider SE, Koboldt DC, Sullivan RP, / et al.: Next-generation sequencing identifies the natural killer cell microRNA transcriptome. / Genome Res 2011,20(11):1590鈥?604. CrossRef
33. Farazi TA, Horlings HM, Ten Hoeve JJ, Mihailovic A, Halfwerk H, Morozov P, Brown M, Hafner M, Reyal F, van Kouwenhove M, / et al.: MicroRNA sequence and expression analysis in breast tumors by deep sequencing. / Cancer research 2011,71(13):4443鈥?453. CrossRef
34. Ebhardt HA, Tsang HH, Dai DC, Liu Y, Bostan B, Fahlman RP: Meta-analysis of small RNA-sequencing errors reveals ubiquitous post-transcriptional RNA modifications. / Nucleic Acids Res 2009,37(8):2461鈥?470. CrossRef
35. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino N, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, / et al.: A mammalian microRNA expression atlas based on small RNA library sequencing. / Cell 2007,129(7):1401鈥?414. CrossRef
36. Reid JG, Nagaraja AK, Lynn FC, Drabek RB, Muzny DM, Shaw CA, Weiss MK, Naghavi AO, Khan M, Zhu H, / et al.: Mouse let-7 miRNA populations exhibit RNA editing that is constrained in the 5'-seed/cleavage/anchor regions and stabilize predicted mmu-let-7a:mRNA duplexes. / Genome Res 2008,18(10):1571鈥?581. CrossRef
37. Langmead B, Trapnell C, Pop M, Salzberg SL: Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. / Genome biology 2009,10(3):R25. CrossRef
38. Pruitt KD, Tatusova T, Klimke W, Maglott DR: NCBI Reference Sequences: current status, policy and new initiatives. / Nucleic Acids Res 2009,37(Database issue):D32鈥?6. CrossRef
39. Chan PP, Lowe TM: GtRNAdb: a database of transfer RNA genes detected in genomic sequence. / Nucleic Acids Res 2009,37(Database issue):D93鈥?7. CrossRef
40. Pruesse E, Quast C, Knittel K, Fuchs BM, Ludwig W, Peplies J, Glockner FO: SILVA: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. / Nucleic Acids Res 2007,35(21):7188鈥?196. CrossRef
41. Liu C, Bai B, Skogerbo G, Cai L, Deng W, Zhang Y, Bu D, Zhao Y, Chen R: NONCODE: an integrated knowledge database of non-coding RNAs. / Nucleic Acids Res 2005,33(Database issue):D112鈥?15. CrossRef
42. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, / et al.: Real-time quantification of microRNAs by stem-loop RT-PCR. / Nucleic Acids Res 2005,33(20):e179. CrossRef
43. Li C, Li X, Miao Y, Wang Q, Jiang W, Xu C, Li J, Han J, Zhang F, Gong B, / et al.: SubpathwayMiner: a software package for flexible identification of pathways. / Nucleic Acids Res 2009,37(19):e131. CrossRef
44. Li SC, Chan WC, Lai CH, Tsai KW, Hsu CN, Jou YS, Chen HC, Chen CH, Lin WC: UMARS: Un-MAppable Reads Solution. / BMC Bioinformatics 2011,12(Suppl 1):S9. CrossRef
45. Chen SJ, Chen GH, Chen YH, Liu CY, Chang KP, Chang YS, Chen HC: Characterization of Epstein-Barr virus miRNAome in nasopharyngeal carcinoma by deep sequencing. / PloS one 2010.,5(9):
46. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, / et al.: Combinatorial microRNA target predictions. / Nat Genet 2005,37(5):495鈥?00. CrossRef
47. Rajewsky N: microRNA target predictions in animals. / Nat Genet 2006, (38 Suppl):S8鈥?3.
48. Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R: Fast and effective prediction of microRNA/target duplexes. / RNA (New York, NY 2004,10(10):1507鈥?517. CrossRef
49. Thadani R, Tammi MT: MicroTar: predicting microRNA targets from RNA duplexes. / BMC Bioinformatics 2006,7(Suppl 5):S20. CrossRef
50. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q, Qin L, Wu X, Zheng Y, Yang Y, / et al.: Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. / Cancer Cell 2011,19(2):232鈥?43. CrossRef
51. Dhillon AS, Hagan S, Rath O, Kolch W: MAP kinase signalling pathways in cancer. / Oncogene 2007,26(22):3279鈥?290. CrossRef
52. Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celia-Terrassa T, Mercatali L, Khan Z, Goodarzi H, Hua Y, / et al.: Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. / Nature medicine 2011,17(9):1101鈥?108. CrossRef
53. Eades G, Yao Y, Yang M, Zhang Y, Chumsri S, Zhou Q: miR-200a regulates SIRT1 expression and epithelial to mesenchymal transition (EMT)-like transformation in mammary epithelial cells. / The Journal of biological chemistry 2011,286(29):25992鈥?6002. CrossRef
54. Gregory PA, Bracken CP, Smith E, Bert AG, Wright JA, Roslan S, Morris M, Wyatt L, Farshid G, Lim YY, / et al.: An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. / Molecular biology of the cell 2011,22(10):1686鈥?698. CrossRef
55. Oneyama C, Ikeda J, Okuzaki D, Suzuki K, Kanou T, Shintani Y, Morii E, Okumura M, Aozasa K, Okada M: MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways. / Oncogene 2011,30(32):3489鈥?501. CrossRef
56. Turcatel G, Rubin N, El-Hashash A, Warburton D: MIR-99a and MIR-99b modulate TGF-beta induced epithelial to mesenchymal plasticity in normal murine mammary gland cells. / PloS one 2012,7(1):e31032. CrossRef
57. Squadrito ML, Pucci F, Magri L, Moi D, Gilfillan GD, Ranghetti A, Casazza A, Mazzone M, Lyle R, Naldini L, / et al.: miR-511鈥?p modulates genetic programs of tumor-associated macrophages. / Cell reports 2012,1(2):141鈥?54. CrossRef - 作者单位：Hong-Tai Chang (1) (2)
Sung-Chou Li (3)
Meng-Ru Ho (4)
Hung-Wei Pan (5)
Luo-Ping Ger (5)
Ling-Yueh Hu (6)
Shou-Yu Yu (5)
Wen-Hsiung Li (4) (7)
Kuo-Wang Tsai (5) (8)
1. Department of Surgery, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, Republic of China
2. Department of Emergency, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, Republic of China
3. Genomics Research Center, Academia Sinica, Taipei, Taiwan, Republic of China
4. Biodiversity Research Center, Academia Sinica, Taipei, Taiwan, Republic of China
5. Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, Republic of China
6. Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan, Republic of China
7. Department of Ecology and Evolution, University of Chicago, Chicago, IL 60637, USA
8. Department of Biotechnology, Tajen University, Taiwan, Republic of China
文摘
Background MicroRNAs (miRNAs) are short noncoding RNAs (approximately 22 nucleotides in length) that play important roles in breast cancer progression by downregulating gene expression. The detailed mechanisms and biological functions of miRNA molecules in breast carcinogenesis have yet to be fully elucidated. This study used bioinformatics and experimental approaches to conduct detailed analysis of the dysregulated miRNAs, arm selection preferences, 3' end modifications, and position shifts in isoforms of miRNAs (isomiRs) in breast cancer. Methods Next-generation sequencing (NGS) data on breast cancer was obtained from the NCBI Sequence Read Archive (SRA). The miRNA expression profiles and isomiRs in normal breast and breast tumor tissues were determined by mapping the clean reads back to human miRNAs. Differences in miRNA expression and pre-miRNA 5p/3p arm usage between normal and breast tumor tissues were further investigated using stem-loop reverse transcription and real-time polymerase chain reaction. Results The analysis identified and confirmed the aberrant expression of 22 miRNAs in breast cancer. Results from pathway enrichment analysis further indicated that the aberrantly expressed miRNAs play important roles in breast carcinogenesis by regulating the mitogen-activated protein kinase (MAPK) signaling pathway. Data also indicated that the position shifts in isomiRs and 3' end modifications were consistent in breast tumor and adjacent normal tissues, and that 5p/3p arm usage of some miRNAs displayed significant preferences in breast cancer. Conclusions Expression pattern and arm selection of miRNAs are significantly varied in breast cancers through analyzing NGS data and experimental approach. These miRNA candidates have high potential to play critical roles in the progression of breast cancer and could potentially provide as targets for future therapy.